Cannabix Technologies stock analysis
Cannabix Technologies (8CT) Stock Price & Analysis
8CT Stock Chart & Stats
- Day’s Range
- EUR 0.23 - EUR 0.23
- 52-Week Range
- EUR 0.18 - EUR 0.55
- Previous Close
- EUR 0.25
- Volume
- N/A
- Average Volume (3M)
- 2,547
- Market Cap
- EUR 27.27M
- Enterprise Value
- EUR 61.64M
- Total Cash (Recent Filing)
- EUR 1.13M
- Total Debt (Recent Filing)
- EUR 125.08K
- Price to Earnings (P/E)
- ―
- Beta
- -0.79
- Next Earnings
- Dec 18, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage
Very low leverage reduces solvency pressure and leaves the company less exposed to interest obligations than a highly indebted peer. Although the capital base is weakening, modest debt gives management more flexibility to fund development without immediate balance-sheet strain.
Multiple Commercial Use Cases
The company is pursuing several institutional applications for its breath-analysis technology rather than relying on one narrowly defined customer segment. If development succeeds, this use-case breadth could support multiple routes to adoption across regulated testing and public-safety markets.
Lower Operating Cash Burn
Operating cash outflow has moderated compared with 2024, indicating some improvement in the pace at which the business consumes funds. The company remains cash-flow negative, but sustained cost discipline could extend funding runway while its technology and workflows continue developing.
Bears Say
Absent Revenue Base
The lack of meaningful reported revenue indicates that commercialization has not yet produced a dependable operating base. Without recurring sales, the company has limited internal funding capacity and remains highly dependent on successful product development and future external financing.
Persistent And Volatile Losses
Large and recurring net losses show that the current business model is not yet economically self-sustaining. The deterioration from 2023 to 2026 annual also demonstrates earnings volatility, making it harder to establish a durable profitability trajectory over the next several quarters.
Cash Burn And Capital Erosion
Sustained negative operating and free cash flow requires ongoing funding, while the sharp decline in shareholders' equity shows that losses are consuming the capital base. This combination can restrict investment capacity and increase reliance on future capital raising to maintain operations.
Cannabix Technologies News
8CT FAQ
What was Cannabix Technologies’s price range in the past 12 months?
What is Cannabix Technologies’s market cap?
When is Cannabix Technologies’s upcoming earnings report date?
How were Cannabix Technologies’s earnings last quarter?
Is Cannabix Technologies overvalued?
Does Cannabix Technologies pay dividends?
What is Cannabix Technologies’s EPS estimate?
How many shares outstanding does Cannabix Technologies have?
What happened to Cannabix Technologies’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cannabix Technologies?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Cannabix Technologies
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law enforcement, workplaces, and laboratories in the United States. It offers Cannabix Marijuana Breath Test (MBT) for Tetrahydrocannabinol (THC) detection and quantification; Cannabix breath collection unit and breath cartridge for human breath sample collection, storage, and transportation. The company also provides BreathLogix alcohol breathalyzer, an autonomous alcohol screening system that enables screening of employees, contractors, and visitors in mining, construction, and oil and gas industries; and BreathLogix Connect (BLC), a cloud platform that is designed for streamlining data. It has a strategic partnership and development agreement with Omega Laboratories Inc. for the development and commercialization of the MBT technology. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.
- Sector
- Healthcare
- Industry
- Other Precious Metals
- CEO
- Ravinder S. Mlait
- Employees
- 0
- Website
- cannabixtechnologies.com
- Address
- 501 - 3292 Production Way, Burnaby, BC, V5A 4R4, CA
Cannabix Technologies (8CT) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 4 | 13 |
| Technical Analysis | 5 | 4 | 1 |
| Moving Averages | 0 | 0 | 12 |










